Back to BlackRock, Inc. BlackRock, Inc.

CLYMCLYM
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CLIMB BIO INC

BlackRock, Inc. holds 2.4M shares of CLYM (CLIMB BIO INC), worth $30.7M as of 2026-Q2. The position was increased (+486.3% shares). CLYM represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$30.7M

Current Shares

2.4M

Total Value Change

+$26.6M

Total Shares Change

+48,617

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+486.3%
$30.7M0.0%$13.04
47
2026-Q1
Increased
401,649
+3.2%
$2.8M0.0%$7.09
18
2025-Q4
Decreased
389,309
-47.1%
$1.6M0.0%$4.03
0
2025-Q3
Decreased
735,503
-16.2%
$1.5M0.0%$1.99
0
2025-Q2
Decreased
877,969
-61.8%
$1.1M0.0%$1.18
0
2025-Q1
Decreased
2.3M
-0.4%
$2.8M0.0%$1.28
0
2024-Q4
New
2.3M
-
$4.2M0.0%$1.85
37

Other major holders of CLYM: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used